• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经尿道前列腺切除术在基于人群的前列腺癌发病率中的作用。

Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.

作者信息

Merrill R M, Feuer E J, Warren J L, Schussler N, Stephenson R A

机构信息

Department of Health Science, Brigham Young University, Provo, UT 84602, USA.

出版信息

Am J Epidemiol. 1999 Oct 15;150(8):848-60. doi: 10.1093/oxfordjournals.aje.a010090.

DOI:10.1093/oxfordjournals.aje.a010090
PMID:10522656
Abstract

The extensive pool of asymptomatic prostate disease in the population, which increases substantially with age, suggests that the frequent use of transurethral resection of the prostate (TURP) in recent decades has had a large effect on prostate cancer incidence. The authors identified the effect of TURP-detected prostate cancer on the observed incidence rates between 1973 and 1993 for men aged 65 years and older. They linked population-based cancer registry data from the Surveillance, Epidemiology, and End Results Program to Medicare records between 1986 and 1993 to determine whether a TURP occurred sufficiently close to the time of a prostate cancer diagnosis for them to assume that it led to the diagnosis. TURP-detected cases prior to 1986 were calculated using an indirect method that involved multiplying the TURP procedure rate in the general population (from the National Hospital Discharge Survey) by estimates of the proportion of TURPs resulting in a prostate cancer diagnosis (from Medicare data and the literature). TURP explained much of the observed increase in overall prostate cancer incidence between 1973 and 1986 and possibly all of it in men aged 70 years and older. However, its influence on the trend and overall magnitude of the rates diminished between 1987 and 1993. The changing role of TURP in detecting prostate cancer is attributed to changes in medical technology and screening practices. The declining influence of TURP on prostate cancer incidence is likely to have continued beyond the study period due to the recent introduction and increasing use of medications for treating obstructive uropathy.

摘要

人群中存在大量无症状前列腺疾病,且其发病率随年龄大幅上升,这表明近几十年来频繁进行经尿道前列腺切除术(TURP)对前列腺癌发病率产生了重大影响。作者确定了1973年至1993年间TURP检测出的前列腺癌对65岁及以上男性观察到的发病率的影响。他们将监测、流行病学和最终结果计划中基于人群的癌症登记数据与1986年至1993年的医疗保险记录相链接,以确定TURP是否在前列腺癌诊断时间足够接近时发生,从而推断其导致了诊断。1986年之前TURP检测出的病例使用间接方法计算,该方法涉及将一般人群中的TURP手术率(来自国家医院出院调查)乘以导致前列腺癌诊断的TURP比例估计值(来自医疗保险数据和文献)。TURP解释了1973年至1986年间观察到的总体前列腺癌发病率增加的大部分情况,对于70岁及以上男性可能解释了全部情况。然而,1987年至1993年间其对发病率趋势和总体幅度的影响有所减弱。TURP在检测前列腺癌中作用的变化归因于医疗技术和筛查实践的改变。由于最近引入并越来越多地使用治疗梗阻性尿路病的药物,TURP对前列腺癌发病率的影响在研究期之后可能仍在持续下降。

相似文献

1
Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.经尿道前列腺切除术在基于人群的前列腺癌发病率中的作用。
Am J Epidemiol. 1999 Oct 15;150(8):848-60. doi: 10.1093/oxfordjournals.aje.a010090.
2
Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate.通过经尿道前列腺切除术偶然发现基于人群的前列腺癌发病率
Urol Oncol. 2002 Sep-Oct;7(5):213-9. doi: 10.1016/s1078-1439(02)00193-x.
3
The diminishing role of transurethral resection of the prostate.经尿道前列腺切除术作用的减弱。
Ann Surg Oncol. 2010 May;17(5):1422-8. doi: 10.1245/s10434-009-0896-4. Epub 2010 Jan 21.
4
The role of increasing detection in the rising incidence of prostate cancer.检测手段增加在前列腺癌发病率上升中所起的作用。
JAMA. 1995 Feb 15;273(7):548-52.
5
Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy.
Urology. 2001 Apr;57(4):733-6. doi: 10.1016/s0090-4295(00)01108-0.
6
Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.经尿道前列腺活检取样在接受良性前列腺增生手术干预的男性中诊断前列腺癌的作用。
Tech Urol. 2000 Sep;6(3):201-4.
7
Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?对于因良性疾病接受经尿道前列腺切除术时偶然诊断出前列腺癌的患者,是否常规进行经直肠前列腺活检?
Urol Int. 2013;91(4):397-403. doi: 10.1159/000350898. Epub 2013 Aug 1.
8
Prostate cancer trends in Canada: rising incidence or increased detection?加拿大前列腺癌的趋势:发病率上升还是检测增加?
CMAJ. 1993 Sep 1;149(5):617-24.
9
Rising incidence of prostate cancer in Scotland: increased risk or increased detection?苏格兰前列腺癌发病率上升:是风险增加还是检测增多?
BJU Int. 2000 Mar;85(4):463-72; discussion 472-3. doi: 10.1046/j.1464-410x.2000.00487.x.
10
Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.经尿道活检或切除诊断的前列腺导管腺癌并不总是提示侵袭性疾病:对临床管理的影响。
BJU Int. 2010 Feb;105(4):476-80. doi: 10.1111/j.1464-410X.2009.08812.x. Epub 2009 Aug 25.

引用本文的文献

1
Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.泌尿系统癌症中的过度诊断:世界泌尿外科学会前列腺癌和肾癌主动监测专题研讨会论文集
World J Urol. 2022 Jan;40(1):1-8. doi: 10.1007/s00345-020-03523-2. Epub 2021 Jan 25.
2
Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?近年来前列腺癌的发病率和手术趋势:是否有过度诊断和过度治疗的趋势?
PLoS One. 2019 Feb 4;14(2):e0210434. doi: 10.1371/journal.pone.0210434. eCollection 2019.
3
Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate: A population-based study.
经尿道前列腺切除术后的前列腺切除重量与术后前列腺癌发病率:一项基于人群的研究。
Medicine (Baltimore). 2019 Jan;98(3):e13897. doi: 10.1097/MD.0000000000013897.
4
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.USPSTF PSA 筛查推荐对美国前列腺癌发病模式的影响。
Nat Rev Urol. 2017 Jan;14(1):26-37. doi: 10.1038/nrurol.2016.251. Epub 2016 Dec 20.
5
Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.美国不同种族致命前列腺癌发病率的趋势
Eur Urol. 2017 Feb;71(2):195-201. doi: 10.1016/j.eururo.2016.05.011. Epub 2016 Jul 27.
6
Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening.在前列腺特异性抗原筛查时代加拿大前列腺癌的发病率和死亡率趋势。
CMAJ Open. 2016 Mar 2;4(1):E73-9. doi: 10.9778/cmajo.20140079. eCollection 2016 Jan-Mar.
7
Model-based patterns in prostate cancer mortality worldwide.全球前列腺癌死亡率的基于模型的模式。
Br J Cancer. 2013 Jun 11;108(11):2354-66. doi: 10.1038/bjc.2013.217. Epub 2013 May 9.
8
Five-year downstream outcomes following prostate-specific antigen screening in older men.老年男性前列腺特异性抗原筛查后的 5 年随访结果。
JAMA Intern Med. 2013 May 27;173(10):866-73. doi: 10.1001/jamainternmed.2013.323.
9
Trends in prostate cancer in the United States.美国前列腺癌的趋势。
J Natl Cancer Inst Monogr. 2012 Dec;2012(45):152-6. doi: 10.1093/jncimonographs/lgs035.
10
Prostate cancer epidemiology in the United States.美国的前列腺癌流行病学。
World J Urol. 2012 Apr;30(2):195-200. doi: 10.1007/s00345-012-0824-2. Epub 2012 Apr 5.